EDETEK Inc. offers an integrated digital solution for clinical trial management, focusing on interoperability, data quality, and timely submissions. The self-described services include clinical data management and biostatistics.

EDETEK Inc.

EDETEK Inc. | 2,650 followers on LinkedIn. Revolutionizing clinical trials through an integrated digital solution promoting interoperability &amp; real time processing | EDETEK provides comprehensive metadata driven solutions to fulfill an enterprise&#39;s data engineering and business analytics needs, through excellence in technology and its applications, plus deep and broad IT industry knowledge. Our platform and solutions are based on industry standards and best practices. Our company works WITH you as your business Partner to develop precisely targeted solutions to meet and exceed your firm&#39;s critical data management and analysis objectives.

Jian Chen

Jody L. Ward

Integration Solution Architect at Edetek

Walter Ochipinti

Strategy | Leadership | Innovation | Results | Speaker - Clinical information systems leader with extensive experience in pharma and biotech software…

Munther Baara

🚀 Exciting News! 🚀 We are thrilled to announce that EDETEK Inc. has been recognized as the highest Major Contender in Everest Group’s 2024 Clinical Data and Analytics (CD&A) Platforms PEAK Matrix® Assessment! 🏆 “We are honored with this prestigious recognition by Everest Group in their 2024 PEAK Matrix® Assessment,” said Dr. Shakthi Kumar, Chief Strategy and Business Officer at EDETEK. “This acknowledgment underscores recent advancements in our capabilities, including Artificial Intelligence (AI) and our commitment to delivering innovative and high-quality solutions.” Click here for the full press release https://lnkd.in/eZYnADYi “EDETEK’s CONFORM platform is scalable and flexible, and offers comprehensive data and analytics capabilities, including robust data integration capabilities. With many use cases in development and production stage, it also demonstrates a strong focus on AI. These capabilities, complemented by excellent client and project management, have helped it earn a Major Contender position in Everest Group’s Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024.", said Nisarg Shah , Practice Director at Everest Group . This recognition underscores EDETEK’s rising leadership, unwavering commitment to innovation, and excellence in the life sciences industry. Our CONFORM™ platform continues to set new standards, driving efficiency and precision in clinical trials through: 🔹 Scalability and Flexibility: Our platform adapts to the evolving needs of clinical trials with ability to handle varying sizes and complexity, ensuring seamless data integration and management. 🔹 AI-Driven Insights: Leveraging cutting-edge AI and generative AI, we automate routine tasks, generate actionable insights, and enhance quality and risk management. 🔹 Client-Centric Approach: Our dedication to excellent client and project management ensures that we deliver high-quality, innovative solutions tailored to our clients’ needs. 🔹 End-to-End Capabilities: From data capture to advanced visualization and analytics, our comprehensive platform supports the entire clinical trial lifecycle, simplifying data aggregation and boosting efficiency. 🔹 Therapeutic-specific Accelerators: Our platform is customized with specific needs of a therapeutic area (for instance, ONCO+ for oncology), providing rich libraries of preconfigured metadata, statistical and medical alerts, near real-time data orchestration, and visualization. Thank you to our valued clients and partners for your trust, confidence, and support. Together, we are transforming the future of clinical trials! 🌟 Jian Chen Shakthi Kumar Peter Smilansky Munther Baara Anatoly Podstrelov Michele Cherry Kevin Prizeman Craig Lipset , John F. Kouten Michael W. Young Jody L. Ward , Haicui Wang Nisarg Shah Manu Aggarwal #AI #biotech #pharma #ClinicalTrials #ClinicalResearch #ClinicalOperations #ClinicalData #DataManagement #CloudComputing #EDETEK #EVEREST #lifesciences

🌍 Honoring Veterans Worldwide 🌍 Today we honor Veterans Day, Armistice Day and Remembrance Day and extend our gratitude to those who have served. Your courage, dedication, and sacrifices have paved the way for a safer and more secure world. Your resilience and commitment to excellence is an inspiration to all of us. Today, we honor not only the veterans within our community but also those who continue to serve and protect us. Thank you for your service. We are proud to support and stand with you.

EDETEK GLOBAL SYNERGY CONNECTING TALENT, DRIVING INNOVATION At EDETEK, we harness the power of our global teams to drive innovation and deliver exceptional value to our client sponsors. Recently, our CEO and President, Mr. Jian Chen , visited our satellite offices in Beijing, China, where he engaged with our talented team. They showcased impressive case studies and highlighted exciting advancements in AI/ML, data orchestration, and visualization. “I was extremely impressed with the passion, dedication, and commitment of our teams to help realize our vision of delivering innovative clinical solutions for a healthier future. Thank you all for your hard work and contributions,” said Mr. Jian Chen. We take immense pride in the strength and diversity of our entire EDETEK team. Munther Baara , Shakthi K. , Michele Cherry , Kevin Prizeman , Craig Lipset , John F. Kouten , Michael W. Young , Jody L. Ward , Haicui Wang , Rui Niu, Yanchun Xie, Fengbin Zhu, Yongqing Zhao, Wenbin Liu, Pingyang Li

Congratulations to EDETEK Inc. Senior Vice President, Product Strategy Peter Smilansky for being featured in CIO Business World 's "The 10 Most Innovative Pharma and Biotech Solution Providers, 2024" cover story! We are thrilled that Edetek's and Peter's expertise and insight are being shared. Munther Baara , Jian Chen , Shakthi K. , Michele Cherry , Kevin Prizeman , Craig Lipset , John F. Kouten , Michael W. Young #AI #biotech #pharma #clinicaltrial #biotech #oncologytrials #ClinicalResearch #ClinicalOperations #ClinicalData #datamanagement #ClinicalManagement #cloudcomputing #AI #EDETEKCONFORM #CIOBusinessWorld

EDETEK Inc. wishes everyone a joyous and prosperous Diwali filled with light, love, and new beginnings. This festival reminds us of the power of unity, positivity, and the importance of celebrating each step towards growth. To all our client sponsors, partners, and associates, we are privileged to continue working together towards new advances in clinical research and development, and better therapies for all. Here’s to a year of greater success, happiness, and health for everyone!

EDETEK Inc. has announced the launch of CONFORM™ – ONCO+, a therapeutic area-specific accelerator designed for oncology protocols inclusive of Phase 1, 2, 3, or 4. Designed to significantly improve cancer clinical trial and data management, this accelerator significantly enhances performance and efficiency by leveraging the latest advancements in Artificial Intelligence (AI)-driven analytics and advanced data management techniques. “Our new accelerators deliver the essential business functionality and outcomes that our client sponsors have been seeking for their clinical trials, offering unparalleled efficiency and precision in data management and analytics,” said Dr. Shakthi Kumar, Chief Strategy and Business Officer, EDETEK. “By leveraging our robust data pipelines and AI with therapeutic area-specific extensions, we empower our client sponsors to conduct more effective and compliant trials, ultimately benefiting patient outcomes and accelerating the development of new therapies.” Learn more at https://lnkd.in/eTMJD8KX To schedule a demo, reach out to sales@edetek.com or http://www.edetek.com . Munther Baara , Jian Chen , Shakthi K. , Peter Smilansky , Michele Cherry , Kevin Prizeman , Craig Lipset , John F. Kouten , Michael W. Young #AI #biotech #clinicaltrial #biotech #oncologytrials #ClinicalResearch #ClinicalOperations #ClinicalData #datamanagement #ClinicalManagement #cloudcomputing #AI #EDETEKCONFORM #oncology #CDISC #CRO #lifesciences

Join EDETEK at the 2024 CDISC+TMF US Interchange Conference in Scottsdale, AZ on October 21-22! Visit us at Booth #9 for an exclusive demo of our CONFORM™ Platform. Discover how our platform transforms your clinical data into a strategic asset, delivering advanced analytics and AI-driven insights. Experience its trial-tested ability to orchestrate a superior sponsor and site experience through its end-to-end, integrated digital data management solution. See how the CONFORM™ platform can harmonize your complex clinical data, providing seamless data review and analytics. Uncover the power of CONFORM™ Chat. IQ, which uses AI to make data visualization easier and more accessible for study teams. Let our EDETEK Inc. experts innovate and elevate your next trial! Munther Baara , Jian Chen , Shakthi K. , Peter Smilansky , Michele Cherry , Kevin Prizeman , Craig Lipset , John F. Kouten , Michael W. Young , CDISC #CDM #CDISC #AI #biotech #clinicaltrial #biotech #oncologytrials #CNStrials #ClinicalResearch #ClinicalOperations #ClinicalData #datamanagement #ClinicalManagement #cloudcomputing #AI #EDETEKCONFORM

EDETEK Inc. 's VP of Strategy & Innovation, Munther Baara , sat down with Applied Clinical Trials Magazine Editor Nicholas Saraceno at #DPHARM2024 to share insights on how AI/ML models are transforming clinical trial data management. Munther introduced the metaphor of travelers to illustrate the industry's journey from paper-based trials to AI-driven predictive analytics, emphasizing the need for real-time data flow. He also discussed EDETEK’s "Four Cs" (Connect, Collect, Conform, and Consume), highlighting how flexible data integration and curation are the keys to unlocking the full potential of AI/ML models. https://lnkd.in/ecbZ3cvc Jian Chen , Shakthi K. , Peter Smilansky , Michele Cherry , Kevin Prizeman , Craig Lipset , John F. Kouten , Michael W. Young #clinicaltrials #decentralizedtrials #trialdiversity #AI #clinicaldatamanagement #clinicaldata #clinicaloperations #ClinicalResearch #digitaldata #DataScience #biopharma

ICYMI: Hear the informative discussion between Munther Baara , Edetek V.P., Product Strategy and Innovation and The Virtual Shift host Tom Foley as they examine how E-clinical technologies have changed the clinical research industry and healthcare IT landscape. They also explore key trends behind the growth of clinical data management technologies and the positive impact improved data management is having on clinical trial design, clinical trial implementation, and accelerated drug development. Listen on-demand at https://lnkd.in/e-xEYVWP Jian Chen , Peter Smilansky , Michele Cherry , Kevin Prizeman , Craig Lipset , John F. Kouten , Michael W. Young #TheVirtualShift #HealthcareNOWRadio #healtIT #virtualcare #healthcare #datasecurity #dataprivacy #cybersecurity #ClinicalResearch #ClinicalOperations #clinicaldata #clinicaldevelopment #datamanagement #cloudcomputing #EDETEKCONFORM #AI

Metric
Company Name	EDETEK Inc.
Symbol
MSH ID	COM:EDETEK
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Health Technology
Country	US
Stage
Employee Count
Website	edetek.com
LinkedIn	edetek
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

EDET

COM:EDETEK

EDETEK Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue